<DOC>
	<DOCNO>NCT00596726</DOCNO>
	<brief_summary>To demonstrate device safe potentially efficacious use leave ventricular cardiac assist device postcardiotomy patient require hemodynamic support post wean cardiopulmonary bypass .</brief_summary>
	<brief_title>RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety Feasibility Study</brief_title>
	<detailed_description>To demonstrate device safe potentially efficacious use leave ventricular cardiac assist device postcardiotomy patient require hemodynamic support post wean cardiopulmonary bypass . Postcardiotomy patient , wean cardiopulmonary bypass system ( CPB ) need hemodynamic support due ineffective standard medical therapy consider enrollment . An attempt shall make reverse hemodynamic situation medication ( e.g . inotropes , vasopressor ) . The IMPELLA RECOVER LP/LD 5.0 implant surgeon improvement hemodynamics observe .</detailed_description>
	<criteria>BSA Receiving stable infusion one high dose inotrope two medium dose inotropes respective minimum time indicate . C.I . Elevated Filling Pressures , PCWP PA Time enrollment within 48 hour wean Renal dysfunction Hepatic dysfunction Right Ventricular failure define . LV RV Thrombus Other exclusion per protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>All patient present high-risk cardiac surgery might post-operatively meet study inclusion criterion potential study candidate .</keyword>
</DOC>